Arrowhead Pharmaceuticals Inc (ARWR)
18.54
+0.26
(+1.42%)
USD |
NASDAQ |
Nov 22, 16:00
18.53
-0.01
(-0.05%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Price to Book Value: 6.973 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 6.973 |
| November 21, 2024 | 6.875 |
| November 20, 2024 | 7.037 |
| November 19, 2024 | 6.995 |
| November 18, 2024 | 7.153 |
| November 15, 2024 | 6.984 |
| November 14, 2024 | 8.052 |
| November 13, 2024 | 8.135 |
| November 12, 2024 | 8.090 |
| November 11, 2024 | 8.263 |
| November 08, 2024 | 8.233 |
| November 07, 2024 | 8.045 |
| November 06, 2024 | 8.026 |
| November 05, 2024 | 7.736 |
| November 04, 2024 | 7.544 |
| November 01, 2024 | 7.33 |
| October 31, 2024 | 7.232 |
| October 30, 2024 | 7.413 |
| October 29, 2024 | 7.514 |
| October 28, 2024 | 7.590 |
| October 25, 2024 | 7.559 |
| October 24, 2024 | 7.496 |
| October 23, 2024 | 7.492 |
| October 22, 2024 | 7.665 |
| October 21, 2024 | 7.706 |
| Date | Value |
|---|---|
| October 18, 2024 | 7.966 |
| October 17, 2024 | 7.838 |
| October 16, 2024 | 7.936 |
| October 15, 2024 | 7.477 |
| October 14, 2024 | 7.281 |
| October 11, 2024 | 6.935 |
| October 10, 2024 | 6.657 |
| October 09, 2024 | 6.709 |
| October 08, 2024 | 6.777 |
| October 07, 2024 | 6.818 |
| October 04, 2024 | 7.078 |
| October 03, 2024 | 7.089 |
| October 02, 2024 | 7.228 |
| October 01, 2024 | 7.213 |
| September 30, 2024 | 7.285 |
| September 27, 2024 | 7.398 |
| September 26, 2024 | 7.379 |
| September 25, 2024 | 7.304 |
| September 24, 2024 | 7.574 |
| September 23, 2024 | 7.522 |
| September 20, 2024 | 7.823 |
| September 19, 2024 | 7.950 |
| September 18, 2024 | 7.815 |
| September 17, 2024 | 7.526 |
| September 16, 2024 | 7.691 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.179
Minimum
Mar 18 2020
30.44
Maximum
Jan 10 2024
11.95
Average
9.882
Median
Price to Book Value Benchmarks
| Vaxcyte Inc | 3.229 |
| CEL-SCI Corp | 4.324 |
| AIM ImmunoTech Inc | 4.596 |
| IGC Pharma Inc | 3.738 |
| NovaBay Pharmaceuticals Inc | 3.121 |
Price to Book Value Related Metrics
| PS Ratio | 11.79 |
| PEG Ratio | -0.0757 |
| Price | 18.54 |
| Earnings Yield | -25.13% |
| Market Cap | 2.305B |
| PEGY Ratio | -0.0757 |